These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3615986)

  • 1. Multistage model interpretation of additive and multiplicative carcinogenic effects.
    Gibb HJ; Chen CW
    Risk Anal; 1986 Jun; 6(2):167-70. PubMed ID: 3615986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additive and multiplicative models and multistage carcinogenesis theory.
    Brown CC; Chu KC
    Risk Anal; 1989 Mar; 9(1):99-105. PubMed ID: 2710973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additive and multiplicative relative risk in the two-stage clonal expansion model of carcinogenesis.
    Kodell RL; Krewski D; Zielinski JM
    Risk Anal; 1991 Sep; 11(3):483-90. PubMed ID: 1947353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting the risk of tumor occurrence under the effect of small doses of carcinogens.
    Yanysheva NY; Antomonov YG
    Environ Health Perspect; 1976 Feb; 13():95-9. PubMed ID: 1269513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multistage carcinogenesis.
    Lancet; 1980 Feb; 1(8163):295. PubMed ID: 6101747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public health implications of carcinogenic exposure under the multistage model.
    Gaffney M; Altshuler B
    Am J Epidemiol; 1986 Dec; 124(6):1021-30. PubMed ID: 3776967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The use and utility of multistage models of carcinogenesis in cohort studies].
    Piolatto G; Pira E; Meliga F
    Med Lav; 1994; 85(1):78-83. PubMed ID: 8035749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of additive and multiplicative models for reproductive risk factors and post-menopausal breast cancer.
    Lund E
    Stat Med; 1995 Feb; 14(3):267-74. PubMed ID: 7724912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multistage models of carcinogenesis.
    Armitage P
    Environ Health Perspect; 1985 Nov; 63():195-201. PubMed ID: 3908088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An exposure driven functional model of carcinogenesis.
    Lund E
    Med Hypotheses; 2011 Aug; 77(2):195-8. PubMed ID: 21550177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination effects of forty carcinogens administered at low doses to male rats.
    Takayama S; Hasegawa H; Ohgaki H
    Jpn J Cancer Res; 1989 Aug; 80(8):732-6. PubMed ID: 2511179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between human carcinogens.
    Kaldor JM; L'Abbé KA
    IARC Sci Publ; 1990; (104):35-43. PubMed ID: 2228132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of carcinogens within the IARC monograph program.
    Vainio H; Wilbourn J
    Scand J Work Environ Health; 1992; 18 Suppl 1():64-73. PubMed ID: 1411382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multistage model of carcinogenesis incorporating DNA damage and repair.
    Portier CJ; Kopp-Schneider A
    Risk Anal; 1991 Sep; 11(3):535-43. PubMed ID: 1947359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facts and theories concerning the mechanisms of carcinogenesis.
    Pitot HC; Dragan YP
    FASEB J; 1991 Jun; 5(9):2280-6. PubMed ID: 1860619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular mechanisms of initiation and promotion of multistage chemical carcinogenesis].
    Khudoleĭ VV
    Vopr Onkol; 1985; 31(2):94-9. PubMed ID: 3883654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of chemical carcinogenesis.
    Miller EC; Miller JA
    Cancer; 1981 Mar; 47(5 Suppl):1055-64. PubMed ID: 7016297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multistage carcinogenesis: implications for risk estimation.
    Yamasaki H
    Cancer Metastasis Rev; 1988 Apr; 7(1):5-18. PubMed ID: 3293832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic carcinogens: problems with identification and risk estimation.
    Hooper K
    J Toxicol Clin Toxicol; 1984; 22(3):283-9. PubMed ID: 6502791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linear-No-Threshold Default Assumptions for Noncancer and Nongenotoxic Cancer Risks: A Mathematical and Biological Critique.
    Bogen KT
    Risk Anal; 2016 Mar; 36(3):589-604. PubMed ID: 26249816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.